Skip to main content
logo
VISEN Pharmaceuticals (HKG:2561)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
19.26
-0.29 (-1.48%)
Jul 31, 2026, 4:08 PM HKT

VISEN Pharmaceuticals Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
0.140.142.78-1.67-2.3
Revenue Growth
-83.83%-95.10%---
Gross Profit
-0.01-0.012.78-1.67-2.3
Operating Income
-239.82-239.82-174.18-139.3-359.29
Net Income
-253.42-253.42-182.24-249.57-288.97
Earnings Per Share
-2.44-2.44-1.95-2.67-
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
632.65632.65203.59347.78626.46
Total Debt
176.99176.992.363.656
Net Cash (Debt)
455.66455.66201.23344.13620.46
Net Cash Growth
-43.38%126.44%-41.53%-44.54%-
Net Cash Per Share
4.404.402.153.68-

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-447.58-447.58-140.86-271.31-246.55
Capital Expenditures
-1.49-1.49-0.12-0.52-1.48
Free Cash Flow
-449.07-449.07-140.98-271.83-248.03
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
-7.35%-7.35%100.00%--
Operating Margin
-176338.97%-176338.97%-6272.16%--
Pretax Margin
-186339.71%-186339.71%-6562.55%14953.27%12574.72%
Profit Margin
-186339.71%-186339.71%-6562.55%--
FCF Margin
-330200.00%-330200.00%-5076.52%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
13876.0022761.01---